Crystal Genomics ranked among the top searched stocks on 2 days within the past month.


As of 9:30 AM on the 25th, Crystal Genomics is trading at 16,100 KRW, up 2.88% from the previous day. This marks a 20.6% increase compared to February 24. Crystal Genomics is known as a specialized company in new drug development, including treatments for arthritis and novel antibiotics.

Over the past 5 days, individual investors have net sold 45,719 shares, while foreign investors and institutions have net bought 73,918 shares and net sold 22,178 shares, respectively.



※Source: AI Investment Assistant AI Racciro


※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing